Ospedale Dei Castelli
Ariccia, Rome, 00040, Italy
NCT Number: NCT04892966
This two parallel arms, randomized, multicenter trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of adenoma detection. Secondary aims will be advanced adenoma detection rate, serrated polyp/adenoma detection rate, as well as procedure variables such as withdrawal time.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Ariccia, Rome, 00040, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard Colonoscopy using TXI imaging
Standard Colonoscopy using White Light Imaging
Time frame: 1 year
the proportion of participants with at least one adenoma (per-patient analysis)
Time frame: 1 year
as the proportion of participants with at least one advanced adenoma at a per-patient analysis
Time frame: 1 year
the total number of detected lesions in each group divided by the total number of participants (per polyp analysis)
Time frame: 1 year
the total number of detected lesions in each group divided by the total number of participants (per-polyp analysis)
Time frame: 1 year
Time from the start of the inspection at the cecum and the withdrawal of the colonoscope from the body of the patient.
University of Roma La Sapienza
Other
Texture and Color Enhancement Imaging (TXI) Versus Standard White-light (WLI) Colonoscopy for Colorectal Adenoma Detection: a Multicenter, Randomized, Trial
Acronym: TRACK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05545787
Colorectal Polyp
Beijing, Beijing Municipality, China
View Trial DetailsNCT06791395
Colonic Diseases, Colorectal Neoplasms
Changchun, Jilin, China
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial DetailsNCT05489380
Colorectal Polyp
Indianapolis, Indiana, United States
View Trial Details